Xue Feng

机构：Peking University, Peking University People's Hospital, Shandong Provincial QianFoShan Hospital, Shandong First Medical University · ORCID：0000-0001-7575-389X

发表论文 72 篇 · 总被引 440 次 · h-index 10

代表论文

• A new andrographolide derivative ADA targeting SIRT3-FOXO3a signaling mitigates cognitive impairment by activating mitophagy and inhibiting neuroinflammation in Apoe4 mice (2023 · Phytomedicine · 被引 41)
• Targeting mitophagy for depression amelioration: a novel therapeutic strategy (2023 · Frontiers in Neuroscience · 被引 27)
• Application of DKI and IVIM imaging in evaluating histologic grades and clinical stages of clear cell renal cell carcinoma (2023 · Frontiers in Oncology · 被引 14)
• Baduanjin for ischemic heart failure with mildly reduced/preserved ejection fraction (BEAR Trial): A randomized controlled trial (2024 · Journal of Evidence-Based Medicine · 被引 13)
• MRI denoising with a non‐blind deep complex‐valued convolutional neural network (2024 · NMR in Biomedicine · 被引 12)
• QiShenYiQi pill inhibits atherosclerosis by promoting TTC39B-LXR mediated reverse cholesterol transport in liver (2023 · Phytomedicine · 被引 10)